Youtube
BAFNAPH

Bafna Pharmaceuticals Ltd Share Price

₹119.8

Score

33

Technically Bearish

Bafna Pharmaceuticals Share Price - 1 Year Trend

Bafna Pharmaceuticals Price Change Analysis

Bafna Pharmaceuticals Key Statistics
  • P/E Ratio

    49.1

  • PEG Ratio

    0.2

  • Market Cap Cr

    283.4

  • Price to Book Ratio

    27.5

  • EPS

    2.5

  • Dividend

    0 ()

  • Relative Strength Index

    41.27

  • Money Flow Index

    59.65

  • MACD Signal

    -1.34

  • Average True Range

    5.92

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Bafna Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Bafna Pharmaceutical belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 71.22 Cr. and Equity Capital is Rs. 23.66 Cr. for the Year ended 31/03/2021. Bafna Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/03/1995 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24294TN1995PLC030698 and registration number is 030698.
  • Market Cap

    280.56

  • Sales

    92.00

  • Shares in Float

    0.24

  • No of Funds

  • Yield

  • Book Value

    5.2

  • U/D Vol Ratio

    0.4

  • LTDebt/Equity

    4

  • Alpha

    -0.01

  • Beta

    1.01

Bafna Pharmaceuticals Ownership
Bafna Pharmaceuticals Management

Bafna Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Bafna Pharmaceuticals Financials

Bafna Pharmaceuticals Technicals

EMA & SMA

CURRENT PRICE

EMA

Bafna Pharmaceuticals Resistance and Support

Bafna Pharmaceuticals Delivery and Volume

Bafna Pharmaceuticals Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Bafna Pharmaceuticals share price is

Open Demat Account